Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target (Q38106992)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 16 May 2013

Language	Label	Description	Also known as
English	Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target	scientific article published on 16 May 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1 reference

based on heuristic

inferred from title

object named as

Nick Devoogdt

2

0 references

Serge Muyldermans

object named as

Serge Muyldermans

4

0 references

author name string

Jens De Vos

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Tony Lahoutte

3

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

language of work or name

0 references

publication date

16 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Expert Opinion on Biological Therapy

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1149-1160

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Molecular imaging in drug development

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Peptide-based probes for targeted molecular imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Protein-based tumor molecular imaging probes

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

The future of molecular imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Molecular imaging: 18F-FDG PET and a whole lot more.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Imaging of the unstable plaque: how far have we got?

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

A review of molecular imaging studies reaching the clinical stage

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Use of (64)Cu-labeled fibronectin domain with EGFR-overexpressing tumor xenograft: molecular imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Naturally occurring antibodies devoid of light chains

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Camelid immunoglobulins and nanobody technology.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Immuno-imaging using nanobodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Molecular imaging using Nanobodies: a case study.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Engineered antibody fragments and the rise of single domains

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Efficient tumor targeting by single-domain antibody fragments of camels

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Selection and characterization of HER2/neu-binding affibody ligands

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Structure of a nanobody-stabilized active state of the β(2) adrenoceptor

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Single-domain antibody fragments with high conformational stability

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Shedding light onto live molecular targets

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

In vivo detection of amyloid-β deposits using heavy chain antibody fragments in a transgenic mouse model for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood-brain barrier

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Kinetic analysis of novel mono- and multivalent VHH-fragments and their application for molecular imaging of brain tumours.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobodies as tools for in vivo imaging of specific immune cell types

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Differential tumor-targeting abilities of three single-domain antibody formats

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobody-coupled microbubbles as novel molecular tracer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Drug transport across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Site-Specific Labeling of His-Tagged Nanobodies with 99mTc: A Practical Guide

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Identifiers

10.1517/14712598.2013.800478

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38106992&oldid=2169219829"